MASHINIi

Celldex Therapeutics, Inc..

CLDX.US | Manufacture of pharmaceuticals, medicinal chemical and botanical products

Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing and commercializing innovative immunotherapies for cancer and other diseases. They focus on identifying and developing antibodies and other protein-based therapeutics that modulate the immune system to fight disease. T...Show More

Ethical Profile

Mixed.

Celldex Therapeutics, Inc. presents a mixed ethical profile. Its 2024 CEO to median employee pay ratio of 39:1 is considered relatively fair, and Glassdoor reviews average 3.9/5 stars with 68% recommending, though some reports suggest salaries may be lower than the Boston average. While Celldex's mission develops treatments for unmet medical needs like chronic urticarias, critics point to potential high pricing impacting future affordability. As a biopharmaceutical firm, it likely relies on animal testing for drug development, creating an inherent conflict with animal welfare, without public disclosure on practices. The company maintains an SEC-required financial concern hotline and has no reported regulatory fines.

Value Scores

Better Health for All0
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect20
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech-10
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

0

No evidence available to assess Celldex Therapeutics, Inc. on Better Health for All.

Fair Money & Economic Opportunity

0

Celldex Therapeutics, Inc. is a biopharmaceutical company focused on developing immunotherapies.

1
Its core business does not involve lending, insuring, moving, or storing money, nor does it operate as a financial institution.
2
Consequently, the company does not offer consumer credit products, manage customer financial data, or engage in activities related to loan or insurance portfolios.
3
Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value, which are designed to assess financial services, are not applicable to Celldex Therapeutics' operations.
4

Fair Pay & Worker Respect

20

The CEO to median employee pay ratio for CLDX.US was 39:1 in 2024, according to SEC proxy statements.

1
Employee reviews indicate an average employee rating of 3.9 out of 5 stars, which translates to approximately 78% engagement.
2
No specific regulatory actions, violations, fines, or compliance issues were mentioned in employee reviews, and no data was available from violation trackers.
3
No specific data was found regarding living wage coverage, collective bargaining, safety incident rates, pay equity ratios, employee turnover, insecure contract share, or health insurance coverage.
4

Fair Trade & Ethical Sourcing

0

The provided articles do not contain specific, quantitative data points for any of the KPIs related to Fair Trade & Ethical Sourcing. There is no information regarding the percentage of spend covered by fair-trade certifications, the frequency of supplier audits, the number of forced or child labor incidents, the traceability coverage of the supply chain, the remediation speed for violations, the percentage of supplier contracts with ethical clauses, the share of spend on high-risk materials, or the procurement budget directed to diverse suppliers.

1
While a Code of Conduct and Business Ethics is mentioned, its scope regarding supplier contracts or specific ethical sourcing practices is not detailed.
2

Honest & Fair Business

-40

Celldex Therapeutics, Inc. maintains a confidential and anonymous financial concern hotline, accessible via a secure web form, for reporting accounting, internal accounting controls, or auditing matters.

1
This system is in place as required by the SEC's final ruling regarding Audit Committees.
2
However, the provided evidence does not include details on independent investigation processes, training frequency, or resolution times for reports made through this channel.

Kind to Animals

0

No evidence available to assess Celldex Therapeutics, Inc. on Kind to Animals.

No War, No Weapons

0

No evidence available to assess Celldex Therapeutics, Inc. on No War, No Weapons.

Planet-Friendly Business

0

No evidence available to assess Celldex Therapeutics, Inc. on Planet-Friendly Business.

Respect for Cultures & Communities

0

No quantitative data on community engagement, reinvestment, cultural impact assessments, grievance mechanisms, FPIC participation, community governance, cultural preservation, local procurement, indigenous suppliers, cultural site protection, social license to operate, charitable giving, community fund allocation, language inclusivity, cultural incident response, or cultural training completion are provided in the available information.

1

Safe & Smart Tech

-10

Celldex Therapeutics has reported no material cybersecurity incidents to date, indicating a perfect security record for a company in a prime target industry.

1
The company maintains a cyber risk management program that includes mandatory periodic security training for all employees, supplemented by phishing tests, and engages third parties for penetration testing, risk consulting, and incident assessment.
2
Celldex is certified for adherence to the EU-U.S., UK Extension, and Swiss-U.S. Data Privacy Framework Principles, and states compliance with GDPR and CCPA/CPRA.
3
However, the company explicitly states it does not respond to "Do Not Track" settings.
4
Celldex collects various categories of personal information, including identifiers and internet activity, and retains it only as long as it serves the notified purpose(s).
5
The company also states it may "share" personal information for cross-context behavioral advertising.
6

Zero Waste & Sustainable Products

0

No specific, quantitative data for CLDX.US related to waste diversion, product recyclability, packaging sustainability, recycled content, single-use plastic reduction, take-back program coverage, circular design principles, waste reduction initiatives, hazardous waste management, product durability, repairability score, waste audit frequency, zero waste certification, waste disposal violations, material efficiency, packaging to product ratio, waste reduction targets, supplier waste requirements, or customer waste education was found in the provided articles.

1
The articles discuss general trends and initiatives within the pharmaceutical industry but do not provide company-specific metrics for Celldex Therapeutics, Inc.
2

Own Celldex Therapeutics, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.